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Inspired by the influential study by Frasure-Smith et al Qournal of the American Medi-
cal Association 1993), in which it was described that depression following myocardial
infarction (MI) was associated with a worse cardiac prognosis, many studies have tried
to replicate this finding. Most of these studies were able to confirm this observation,
however several studies failed to find an association berween post-Ml depression and
impaired cardiovascular prognosis. Nevertheless, depression is considered to be an in-
dependent risk factor for post-Ml prognosis. Indeed, some research groups share the
opinion that depression in the aftermath of MI is causally related to new cardiac events.
Given the previous conficting results, we set out to investigate the association between
post-Ml depression and cardiovascular prognosis in a meta-analysis. \7e selected and
pooled prospective studies in which the effects of depression (within 3 months post-MI)
on cardiovascular mortality and events within 2 years post-Ml was investigated. It was
shown in chapter 2 that post-Ml depression was associated with a 2-2.5 fold increased
risk of cardiovascular mortaliry or cardiovascular events (e.g. recurrent MI, dotter proce-
dures, etcetera). These results support the assumption that post-Ml depression is related
to a worse cardiac prognosis. However, ro satisE/ the criteria of causal inference, effective
treatment of post-Ml depression should lead to a better cardiovascular outcome of de-
pressive MI patients. Therefore, we designed the Myocardial lNfarction and Depression
- Intervention Trial (MIND-IT) (chapter 3). This large randomised controlled study
investigated the influence of antidepressive treatment for depression following MI on
cardiac prognosis. Other objectives were the investigation of antidepressive rrearmenr
for post-Ml depression on a) quality of l i fe b) depression. The study was sponsored
by the Netherlands Heart Foundation. To answer the research questions, MI patients
admitted to l0 hospitals, scattered nationwide, were screened for depressive symptoms
and disorder s. Of 2177 MI patients, screened in the first year posr-MI, 17% fulfi l led the
criteria (lCD-10) of depressive disorder at some timepoint in that year. This percentage
is comparable to results from other research groups. Patients who scored positive for
depressive disorder during a standardised psychiatric interview differed from patients
who remained free from depression on several characteristics. Important predictors of
post-Ml depression were a) young age and b) poor left ventricular function. In combi-
nation with rhe results of a depression questionnaire during hospitalisation, it appeared
to be possible to identif, MI patients with a high risk for subsequent development of
depression. The predictor model (chapter 6) may be of value in rehabilitation and
work-resumption programs of patients who suffered from MI.
In MIND-IT, MI patients with post-Ml depression were randomised to Intervention
(n=2931 or Care as Usual 6=122). Patients randomised to Intervention were offered
antidepressive treatment, which consisted of treatment with mirtazapine, citalopram or















be clear that n
as a temporar
macological tr
This may be o
the specific ser
ment modaliti





















ry studies have tried
rm this observation,
-MI depression and
sidered to be an in-
ch groups share the





L 3 months post-MI)
r investigated, It was
2-2.5 fold increased
nt MI, dotter proce-
depression is related
rl inference, effective
ular outcome of de-
tion and Depression
;ed controlled study

















riatrist). The kind of
treatment realized was not essential for the investigation of the primary objective based
on the assumption that optimal antidepressive treatmenr was provided in rhe Interven-
tion arm, compared with almost negligible antidepressive rrearment in the CAU-arm.
No treatment was offered by MIND-IT investigators in the CAU-arm. The Ênal results
of the MIND-IT study showed that antidepressive treatment did nor improve the car-
diac prognosis of MI parienrs with depression compared to CAU parienrs (chapter 3).
However, for a clear interpretation of the study results, it need to be stressed that due
to the absence of a difference in depression outcome berween the randomisation arms,
it remains undecided whether ffictiue treatment of post-Ml depression can increase
event-free survival.
Two other conclusions can be drawn from the MIND-IT study. Firstly, based on long-
term follow up of depression outcome of CAU patienrs, we showed that most of the de-
pressive patients (-70o/o) were recovered at 18 months posr-Ml. From these data it may
be clear that most of the depressive episodes after MI (but not all!) should be considered
as a temporary mood disorder in response to a life-threatening event. Secondly, phar-
macoiogical treatment of post-Ml depression did not resuit in a better cardiac ourconle.
This may be oIimportance, since recent studies showed that certain antidepressants (i.e.
the specific serotonin re-uptake inhibitors, SSRIs), in conrrasr ro orher psychiatric treat-
ment modalit ies, may have protective properties in ischaemic heart disaese, which could
be due to its effects on blood platelet activation. It must be realized that the antidepres-
sants used within the MIND-IT study, belonged mostly to another phannacological
class than these SSRIs. Therefore, more research is warranted to investigare rhe effecrs of
SSRIs on the cardiovascular system.
One of these initiatives is presented in chapter 5. Ir was shown that one of rhe SSRIs,
sertraline, showed marked vasodilatory effects in rat aorra and human IMAs (Internal
Man-rmary Arteries). Sertraline also elicited vasodilatation in coronary arteries during
perfusion of rat hearts. These hemodynamic effects may be an addirional explanarion
for the putative beneficial effects in myocardial ischemia and infarction. In the same
chapter, the results of another biological study were described. Our objective was ro
investigate the association between the autonomic nervous system, using parameters of
Heart Rate Variability (HRV), and depression in post-MI parienrs. Patients with depres-
sion were characterized by decreased HRV compared to the patients without depression,
independent of other clinical variables. This observation supports rhe concepr rhar one
of the mechanisms underlying the detrimental effect of depression on posr-MI progno-
sis may be that depression adds to the autonomic derangement post-Ml.
Based on MIND-IT data, it was shown that a relationship was found berween left ven,
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tricular ejection fraction (LVEF) and post-MI depressive disorder, i.e. a lower LVEF was
associated with a higher rate of depression in the year post-Ml. The association persisted
after adjustment for demographics, risk factors for coronary artery disease, co-morbid-
ity, heart failure and baseline depression-scores. In addition, the severity of depressive
symptoms was signiÊcantly related to the severity of LV-dysfunction chapter 4.
Given the observed association between depression and LVEF, a closer look at the pos-
sible harmful ingredients of post-Ml depression is opportune. After factor analysis of
thousands of MIND-IT questionnaires, 3 dimensions (i.e. somatic/affective, cognitive/
affective and appetitive symptoms) were related to prospective cardiovascular mortality
and cardiac-related readmissions with a mean follow up duration of 2.5 years. Soma-
tic/affective symptoms of post-MI depression were prospectively associated with cardiac
prognosis. Cognitive/affective symptoms of depression were only marginally related to
prognosis.
In chapter 7, the present status of post-Ml depression is discussed. Future research
questions are formulated. A comparison is made with the situation in 1993 when
Frasure-Smith et ol call attention to the harmful of post-Ml depression. Although it is
clear that depression has detrimental effects on the quality of life of post-Ml patients, it
remains to be elucidated whether depression is causally related to post-Ml cardiac prog-
nosis and whether effective treatment for this disorder can result in an increased cardiac
event-free survival. Irrespective of the effects of post-Ml depression on cardiovascular
prognosis, clinicians need to be open minded for psychic complaints.
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